Drug Type Nanobody |
Synonyms LQ 043H, LQ-043H, LQ043 + [1] |
Target |
Mechanism TSLP modulators(Thymic stromal lymphopoietin modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Asthma | Phase 1 | CN | 27 Feb 2023 |